All4NutraNo products in the cart.
All4NutraStartseite » Quality by Design (QbD) » Page 11
As the pharmaceutical industry increasingly adopts the Pharma 4.0. concept, there is a growing need to effectively predict the product...
Abstract One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and...
Purpose Although understanding the variability in the physicochemical properties of an excipient in a drug formulation is becoming an important...
A QbD-DM3 strategy was used to design ketoprofen (KTF) optimized liquid (L-SNEDDS) and solid self-nanoemulsifying drug delivery systems (S-SNEDDS). Principal component...
Characterization of drug release from modified-release products in the presence of alcohol is required to evaluate the possibility of dose...
Pharmaceutical product development guided by Quality by Design (QbD) is based on a complete understanding of the critical process parameters...
The present study aims to design and optimize the lornoxicam dispersible tablet (LXDT) formulation using the Quality by design (QbD)...
The absence of oral liquid pharmaceutical forms appropriate for use in pediatric and adult patients with difficulty swallowing is a...
Abstract Introduction: More emphasize was given in the present work is application of QbD tools and DoE approach. The existing...
BCS Class II drugs, such as itraconazole (ITZ), exhibit poor solubility (1–4 ng/mL) and so require solubility enhancement. Therefore, ITZ...
Copyright: PharmaExcipients AG